A Study Evaluating the Effectiveness of Ultrasound Imaging for Liver Steatosis Staging

Overview

About this study

The purpose of this study is to investigate the effectiveness of ultrasound imaging for staging liver steatosis, using liver fat content measured by MRI as the reference standard.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Age ≥ 18 years old.
Patients with clinically indicated MRI-PDFF (Proton Density Fat Fraction) for liver imaging.

Exclusion Criteria

Individuals < 18 years old.
Vulnerable subjects such as:
- Prisoners;
- Adults lacking capacity to consent.
Patients with liver iron overload, which may confound PDFF measurements.

Eligibility last updated 11/12/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Shigao Chen, Ph.D.	Open for enrollment	Contact information: Hanarica Pol (507) 422-5118 Pol.Hanarica@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Shigao Chen, Ph.D.

Open for enrollment

Contact information:

Hanarica Pol

(507) 422-5118

Pol.Hanarica@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials